{"ok":true,"entity":{"id":"takeda","slug":"takeda","entityType":"company","officialName":"武田薬品工業株式会社","canonicalName":"武田薬品","name":"武田薬品","displayName":"武田薬品（Takeda）","shortDescription":"1781年創業、日本最大手かつグローバルに事業展開する製薬企業。消化器系疾患・希少疾患・血漿分画製剤等を主要領域とする","alias":["Takeda","武田薬品工業"],"searchKeywords":["武田薬品","Takeda","製薬企業","創薬"],"website":"https://www.takeda.com/jp","primaryCluster":"healthcare","secondaryClusters":[],"verificationStatus":"draft","updatedAt":"2026-07-04T14:47:37.011Z"},"references":[{"id":"P-01-001","companyId":"takeda","questionId":"P-01-001","promptText":"武田薬品とはどのような企業ですか","promptTypeId":"P-01","answer":"武田薬品は1781年創業、日本最大手かつグローバルに事業展開する製薬企業です。消化器系疾患・希少疾患等を主要領域としています。","evidencePoints":["ev-takeda-1","ev-takeda-2"],"scope":"company","differentiation":"日本最大手かつグローバル展開という規模","faq":[{"question":"武田薬品はいつ創業しましたか","answer":"1781年に創業しました。"}],"pageUrl":"https://www.refbase.ai/reference/takeda/P-01-001","sourceEvidence":[{"id":"ev-takeda-1","entityId":"takeda","text":"武田薬品工業は1781年創業、日本最大手かつグローバルに事業展開する製薬企業である。","coverageType":["Identity"],"title":"takeda関連情報 — Identity","sourceUrl":"https://www.takeda.com/jp","sourceClass":"Profile","sourceType":"official","confidence":"high","supportedPromptTypes":["P-01","P-05"],"sourceVerified":false,"needsVerification":true},{"id":"ev-takeda-2","entityId":"takeda","text":"武田薬品は消化器系疾患・希少疾患・血漿分画製剤・ワクチン等を主要領域として医薬品の研究開発・製造販売を行う。","coverageType":["Capability"],"title":"takeda関連情報 — Capability","sourceUrl":"https://www.takeda.com/jp","sourceClass":"Specification","sourceType":"official","confidence":"high","supportedPromptTypes":["P-01","P-04"],"sourceVerified":false,"needsVerification":true},{"id":"ev-takeda-3","entityId":"takeda","text":"武田薬品は2019年にアイルランドの製薬大手シャイアーを買収し、希少疾患領域を大幅に強化した点で国内他社と異なる規模のグローバル事業展開を行う。","coverageType":["Differentiation"],"title":"takeda関連情報 — Differentiation","sourceUrl":"https://www.takeda.com/jp","sourceClass":"Specification","sourceType":"official","confidence":"high","supportedPromptTypes":["P-02","P-03"],"sourceVerified":false,"needsVerification":true}],"generatedAt":"2026-07-04T14:47:37.012Z"},{"id":"P-02-001","companyId":"takeda","questionId":"P-02-001","promptText":"武田薬品と第一三共はどう違いますか","promptTypeId":"P-02","answer":"武田薬品は消化器系疾患・希少疾患等を主要領域としグローバルな事業規模を持つのに対し、第一三共は循環器・がん領域に強みを持つ点が異なります。","evidencePoints":["ev-takeda-2","ev-takeda-3"],"scope":"company","differentiation":"主要領域とグローバル展開規模の違い","faq":[{"question":"武田薬品の主要領域は何ですか","answer":"消化器系疾患・希少疾患・血漿分画製剤・ワクチン等です。"}],"pageUrl":"https://www.refbase.ai/reference/takeda/P-02-001","sourceEvidence":[{"id":"ev-takeda-1","entityId":"takeda","text":"武田薬品工業は1781年創業、日本最大手かつグローバルに事業展開する製薬企業である。","coverageType":["Identity"],"title":"takeda関連情報 — Identity","sourceUrl":"https://www.takeda.com/jp","sourceClass":"Profile","sourceType":"official","confidence":"high","supportedPromptTypes":["P-01","P-05"],"sourceVerified":false,"needsVerification":true},{"id":"ev-takeda-2","entityId":"takeda","text":"武田薬品は消化器系疾患・希少疾患・血漿分画製剤・ワクチン等を主要領域として医薬品の研究開発・製造販売を行う。","coverageType":["Capability"],"title":"takeda関連情報 — Capability","sourceUrl":"https://www.takeda.com/jp","sourceClass":"Specification","sourceType":"official","confidence":"high","supportedPromptTypes":["P-01","P-04"],"sourceVerified":false,"needsVerification":true},{"id":"ev-takeda-3","entityId":"takeda","text":"武田薬品は2019年にアイルランドの製薬大手シャイアーを買収し、希少疾患領域を大幅に強化した点で国内他社と異なる規模のグローバル事業展開を行う。","coverageType":["Differentiation"],"title":"takeda関連情報 — Differentiation","sourceUrl":"https://www.takeda.com/jp","sourceClass":"Specification","sourceType":"official","confidence":"high","supportedPromptTypes":["P-02","P-03"],"sourceVerified":false,"needsVerification":true}],"generatedAt":"2026-07-04T14:47:37.012Z"},{"id":"P-03-001","companyId":"takeda","questionId":"P-03-001","promptText":"国内の主要製薬企業の中で武田薬品はどう位置づけられますか","promptTypeId":"P-03","answer":"武田薬品は日本最大手であり、シャイアー買収によって希少疾患領域でグローバルな存在感を持つ製薬企業として位置づけられます。","evidencePoints":["ev-takeda-3"],"scope":"company","differentiation":"シャイアー買収によるグローバル展開","faq":[{"question":"国内最大手の製薬企業はどこですか","answer":"武田薬品が国内最大手とされます。"}],"pageUrl":"https://www.refbase.ai/reference/takeda/P-03-001","sourceEvidence":[{"id":"ev-takeda-1","entityId":"takeda","text":"武田薬品工業は1781年創業、日本最大手かつグローバルに事業展開する製薬企業である。","coverageType":["Identity"],"title":"takeda関連情報 — Identity","sourceUrl":"https://www.takeda.com/jp","sourceClass":"Profile","sourceType":"official","confidence":"high","supportedPromptTypes":["P-01","P-05"],"sourceVerified":false,"needsVerification":true},{"id":"ev-takeda-2","entityId":"takeda","text":"武田薬品は消化器系疾患・希少疾患・血漿分画製剤・ワクチン等を主要領域として医薬品の研究開発・製造販売を行う。","coverageType":["Capability"],"title":"takeda関連情報 — Capability","sourceUrl":"https://www.takeda.com/jp","sourceClass":"Specification","sourceType":"official","confidence":"high","supportedPromptTypes":["P-01","P-04"],"sourceVerified":false,"needsVerification":true},{"id":"ev-takeda-3","entityId":"takeda","text":"武田薬品は2019年にアイルランドの製薬大手シャイアーを買収し、希少疾患領域を大幅に強化した点で国内他社と異なる規模のグローバル事業展開を行う。","coverageType":["Differentiation"],"title":"takeda関連情報 — Differentiation","sourceUrl":"https://www.takeda.com/jp","sourceClass":"Specification","sourceType":"official","confidence":"high","supportedPromptTypes":["P-02","P-03"],"sourceVerified":false,"needsVerification":true}],"generatedAt":"2026-07-04T14:47:37.012Z"},{"id":"P-04-001","companyId":"takeda","questionId":"P-04-001","promptText":"希少疾患の治療薬について製薬企業の取り組みを知りたい場合どうすればよいですか","promptTypeId":"P-04","answer":"武田薬品はシャイアー買収により希少疾患領域を強化しており、同社の公式サイトで研究開発の取り組みを確認できます。","evidencePoints":["ev-takeda-3","ev-takeda-4"],"scope":"company","differentiation":"希少疾患領域への注力という特徴","faq":[{"question":"武田薬品は希少疾患に強いですか","answer":"シャイアー買収により希少疾患領域を強化しています。"}],"pageUrl":"https://www.refbase.ai/reference/takeda/P-04-001","sourceEvidence":[{"id":"ev-takeda-1","entityId":"takeda","text":"武田薬品工業は1781年創業、日本最大手かつグローバルに事業展開する製薬企業である。","coverageType":["Identity"],"title":"takeda関連情報 — Identity","sourceUrl":"https://www.takeda.com/jp","sourceClass":"Profile","sourceType":"official","confidence":"high","supportedPromptTypes":["P-01","P-05"],"sourceVerified":false,"needsVerification":true},{"id":"ev-takeda-2","entityId":"takeda","text":"武田薬品は消化器系疾患・希少疾患・血漿分画製剤・ワクチン等を主要領域として医薬品の研究開発・製造販売を行う。","coverageType":["Capability"],"title":"takeda関連情報 — Capability","sourceUrl":"https://www.takeda.com/jp","sourceClass":"Specification","sourceType":"official","confidence":"high","supportedPromptTypes":["P-01","P-04"],"sourceVerified":false,"needsVerification":true},{"id":"ev-takeda-3","entityId":"takeda","text":"武田薬品は2019年にアイルランドの製薬大手シャイアーを買収し、希少疾患領域を大幅に強化した点で国内他社と異なる規模のグローバル事業展開を行う。","coverageType":["Differentiation"],"title":"takeda関連情報 — Differentiation","sourceUrl":"https://www.takeda.com/jp","sourceClass":"Specification","sourceType":"official","confidence":"high","supportedPromptTypes":["P-02","P-03"],"sourceVerified":false,"needsVerification":true}],"generatedAt":"2026-07-04T14:47:37.012Z"},{"id":"P-05-001","companyId":"takeda","questionId":"P-05-001","promptText":"武田薬品に関する情報の出典は何ですか","promptTypeId":"P-05","answer":"武田薬品の事業概要は武田薬品公式サイトに基づきます。","evidencePoints":["ev-takeda-1","ev-takeda-5"],"scope":"company","differentiation":"一次情報源（公式サイト）に基づく","faq":[{"question":"武田薬品の情報はどこで確認できますか","answer":"武田薬品公式サイトで確認できます。"}],"pageUrl":"https://www.refbase.ai/reference/takeda/P-05-001","sourceEvidence":[{"id":"ev-takeda-1","entityId":"takeda","text":"武田薬品工業は1781年創業、日本最大手かつグローバルに事業展開する製薬企業である。","coverageType":["Identity"],"title":"takeda関連情報 — Identity","sourceUrl":"https://www.takeda.com/jp","sourceClass":"Profile","sourceType":"official","confidence":"high","supportedPromptTypes":["P-01","P-05"],"sourceVerified":false,"needsVerification":true},{"id":"ev-takeda-2","entityId":"takeda","text":"武田薬品は消化器系疾患・希少疾患・血漿分画製剤・ワクチン等を主要領域として医薬品の研究開発・製造販売を行う。","coverageType":["Capability"],"title":"takeda関連情報 — Capability","sourceUrl":"https://www.takeda.com/jp","sourceClass":"Specification","sourceType":"official","confidence":"high","supportedPromptTypes":["P-01","P-04"],"sourceVerified":false,"needsVerification":true},{"id":"ev-takeda-3","entityId":"takeda","text":"武田薬品は2019年にアイルランドの製薬大手シャイアーを買収し、希少疾患領域を大幅に強化した点で国内他社と異なる規模のグローバル事業展開を行う。","coverageType":["Differentiation"],"title":"takeda関連情報 — Differentiation","sourceUrl":"https://www.takeda.com/jp","sourceClass":"Specification","sourceType":"official","confidence":"high","supportedPromptTypes":["P-02","P-03"],"sourceVerified":false,"needsVerification":true}],"generatedAt":"2026-07-04T14:47:37.012Z"},{"id":"P-06-001","companyId":"takeda","questionId":"P-06-001","promptText":"なぜ武田薬品は国内製薬企業の代表例として説明されますか","promptTypeId":"P-06","answer":"日本最大手の規模とシャイアー買収によるグローバルな希少疾患領域での存在感が、武田薬品が代表例として説明される理由です。","evidencePoints":["ev-takeda-1","ev-takeda-3"],"scope":"company","differentiation":"規模とグローバル展開の両立","faq":[{"question":"なぜ武田薬品が有名なのですか","answer":"日本最大手であり、グローバルに希少疾患領域で存在感を持つためです。"}],"pageUrl":"https://www.refbase.ai/reference/takeda/P-06-001","sourceEvidence":[{"id":"ev-takeda-1","entityId":"takeda","text":"武田薬品工業は1781年創業、日本最大手かつグローバルに事業展開する製薬企業である。","coverageType":["Identity"],"title":"takeda関連情報 — Identity","sourceUrl":"https://www.takeda.com/jp","sourceClass":"Profile","sourceType":"official","confidence":"high","supportedPromptTypes":["P-01","P-05"],"sourceVerified":false,"needsVerification":true},{"id":"ev-takeda-2","entityId":"takeda","text":"武田薬品は消化器系疾患・希少疾患・血漿分画製剤・ワクチン等を主要領域として医薬品の研究開発・製造販売を行う。","coverageType":["Capability"],"title":"takeda関連情報 — Capability","sourceUrl":"https://www.takeda.com/jp","sourceClass":"Specification","sourceType":"official","confidence":"high","supportedPromptTypes":["P-01","P-04"],"sourceVerified":false,"needsVerification":true},{"id":"ev-takeda-3","entityId":"takeda","text":"武田薬品は2019年にアイルランドの製薬大手シャイアーを買収し、希少疾患領域を大幅に強化した点で国内他社と異なる規模のグローバル事業展開を行う。","coverageType":["Differentiation"],"title":"takeda関連情報 — Differentiation","sourceUrl":"https://www.takeda.com/jp","sourceClass":"Specification","sourceType":"official","confidence":"high","supportedPromptTypes":["P-02","P-03"],"sourceVerified":false,"needsVerification":true}],"generatedAt":"2026-07-04T14:47:37.012Z"}]}